Agenus Inc.
(NASDAQ : AGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.41%198.201.2%$509.37m
GILDGilead Sciences, Inc.
0.12%73.680.9%$447.60m
BIIBBiogen Inc.
0.13%331.381.3%$369.09m
CELGCelgene Corporation
0.11%82.671.2%$330.81m
ILMNIllumina, Inc.
-1.02%318.403.5%$287.48m
REGNRegeneron Pharmaceuticals, Inc.
-1.28%379.242.6%$221.08m
ALXNAlexion Pharmaceuticals, Inc.
0.91%123.062.0%$210.66m
VRTXVertex Pharmaceuticals Incorporated
-0.59%180.261.9%$202.29m
SRPTSarepta Therapeutics, Inc.
1.63%132.6216.4%$169.13m
AAgilent Technologies, Inc.
-0.03%66.221.5%$154.50m
BMRNBioMarin Pharmaceutical Inc.
1.09%100.594.4%$129.74m
VKTXViking Therapeutics, Inc.
-1.36%14.260.9%$107.26m
LGNDLigand Pharmaceuticals Incorporated
-1.18%200.2023.3%$106.87m
NKTRNektar Therapeutics
0.68%49.245.6%$106.18m
NBIXNeurocrine Biosciences, Inc.
-0.44%110.995.1%$96.55m

Company Profile

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.